Oruka Therapeutics
ORKA
79.50
-0.68
-0.85%
Oruka Therapeutics
US · ORKA
#2003 by market cap
Listed 1970
79.50
-0.68
-0.85%
Live - 5344 symbols - heartbeat 191s ago
· 2026-10-08 09:16
Pre-market
78.54
-1.21%
After-hours
79.50
0.00%
- Market cap
- 5.26B
- P/E (TTM)i
- -38.97
- P/Bi
- 4.74
- EPSi
- -1.85
- Div yieldi
- 0.00%
- 52W posi
- 60%
Reader sentiment
Are you bullish or bearish on ORKA?
Anonymous reader poll. Unscientific, not investment advice.
About Oruka Therapeutics
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
- CEO
- Dr. Lawrence Otto Klein, PhD
- Employees
- 68
- Headquarters
- Menlo Park, California, United States of America
- Fiscal year end
- 12-31
- Website
- orukatx.com
Company profile
- Exchange
- US
- Symbol
- ORKA
- Market-cap rank
- #2003
- Listing date
- 1970-01-01
- Market cap
- 5.26B
- Float cap
- 4.52B
- Shares out
- 66.21M
- Float shares
- 56.88M
Sectors & themes
Biotechnology
Quote time 2026-10-08 09:16:04 · For reference only, not investment advice and not tailored to your situation.